| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Acknowledgement of reviewers 2021
|
|
|
|
90 |
1 |
p. 105-107
|
article
|
| 2 |
A phase Ib study of Oraxol (oral paclitaxel and encequidar) in patients with advanced malignancies
|
Ma, Wen Wee
|
|
|
90 |
1 |
p. 7-17
|
article
|
| 3 |
A phase I/II study of 10-min dosing of bendamustine hydrochloride (rapid infusion formulation) in patients with previously untreated indolent B-cell non-Hodgkin lymphoma, mantle cell lymphoma, or relapsed/refractory diffuse large B-cell lymphoma in Japan
|
Ishizawa, Kenichi
|
|
|
90 |
1 |
p. 83-95
|
article
|
| 4 |
Aprepitant, fosaprepitant and risk of ifosfamide-induced neurotoxicity: a systematic review
|
Vazirian, Fatemeh
|
|
|
90 |
1 |
p. 1-6
|
article
|
| 5 |
Development of a population pharmacokinetic/pharmacodynamic model for various oral paclitaxel formulations co-administered with ritonavir and thrombospondin-1 based on data from early phase clinical studies
|
van Eijk, Maarten
|
|
|
90 |
1 |
p. 71-82
|
article
|
| 6 |
Efficacy and toxicity of vemurafenib and cobimetinib in relation to plasma concentrations, after administration via feeding tube in patients with BRAF-mutated thyroid cancer: a case series and review of literature
|
van Berge Henegouwen, J. M.
|
|
|
90 |
1 |
p. 97-104
|
article
|
| 7 |
Evaluation of drug–drug interactions between midostaurin and strong CYP3A4 inhibitors in patients with FLT-3-mutated acute myeloid leukemia (AML)
|
Sechaud, Romain
|
|
|
90 |
1 |
p. 19-27
|
article
|
| 8 |
Exposure–response analyses for the MET inhibitor tepotinib including patients in the pivotal VISION trial: support for dosage recommendations
|
Xiong, Wenyuan
|
|
|
90 |
1 |
p. 53-69
|
article
|
| 9 |
Impact of pharmacogenetics on variability in exposure to oral vinorelbine among pediatric patients: a model‐based population pharmacokinetic analysis
|
Hamimed, Mourad
|
|
|
90 |
1 |
p. 29-44
|
article
|
| 10 |
The comparison of plasma arsenic concentration and urinary arsenic excretion during treatment with Realgar-Indigo naturalis formula and arsenic trioxide in children with acute promyelocytic leukemia
|
Liao, Liu-Hua
|
|
|
90 |
1 |
p. 45-52
|
article
|
Journal description